Acrivon Therapeutics, Inc. - Common Stock (NQ: ACRV )
8.860
+0.490
(+5.85%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
All News about Acrivon Therapeutics, Inc. - Common Stock
![](https://cdn.benzinga.com/files/images/story/2023/12/05/daktronics_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's After-Market Session
December 04, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Analyst Ratings for Acrivon Therapeutics
November 10, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Recap: Acrivon Therapeutics Q3 Earnings
November 09, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Analyst Expectations for Acrivon Therapeutics's Future
October 05, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2023
August 18, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg)
Via GlobeNewswire
![](https://investorplace.com/wp-content/uploads/2022/10/stocks-to-buy-greedy1600-1024x576.png)
![](https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg)
Via GlobeNewswire
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg)
Via GlobeNewswire
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://ml.globenewswire.com/media/7935747b-f8f5-48e8-b925-6935300d63e5/small/acrivon-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_6689.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Friday's Intraday Session
April 07, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.